CN111484471A - A kind of preparation method of high psyllium - Google Patents
A kind of preparation method of high psyllium Download PDFInfo
- Publication number
- CN111484471A CN111484471A CN201910083880.6A CN201910083880A CN111484471A CN 111484471 A CN111484471 A CN 111484471A CN 201910083880 A CN201910083880 A CN 201910083880A CN 111484471 A CN111484471 A CN 111484471A
- Authority
- CN
- China
- Prior art keywords
- scutellarin
- preparation
- acid
- reaction
- psyllium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000003421 Plantago ovata Nutrition 0.000 title claims abstract description 33
- 239000009223 Psyllium Substances 0.000 title claims abstract description 33
- 229940070687 psyllium Drugs 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 241001499733 Plantago asiatica Species 0.000 title claims abstract 5
- 238000006243 chemical reaction Methods 0.000 claims abstract description 37
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 claims abstract description 17
- NPLTVGMLNDMOQE-UHFFFAOYSA-N carthamidin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=C(O)C(O)=C2C(=O)C1 NPLTVGMLNDMOQE-UHFFFAOYSA-N 0.000 claims abstract description 17
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 claims abstract description 17
- 229930190376 scutellarin Natural products 0.000 claims abstract description 17
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 45
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 30
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 18
- LNIVUWPCHRNJLG-SXFAUFNYSA-N Scutellarin methyl ester Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](C(=O)OC)O[C@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 LNIVUWPCHRNJLG-SXFAUFNYSA-N 0.000 claims description 18
- LNIVUWPCHRNJLG-UHFFFAOYSA-N scutellarin methyl ester Natural products OC1C(O)C(O)C(C(=O)OC)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 LNIVUWPCHRNJLG-UHFFFAOYSA-N 0.000 claims description 18
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 8
- 239000007858 starting material Substances 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 8
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 7
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical group CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 5
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 239000003377 acid catalyst Substances 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- 239000007810 chemical reaction solvent Substances 0.000 claims description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 3
- 150000007529 inorganic bases Chemical class 0.000 claims description 3
- 229910017604 nitric acid Inorganic materials 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 235000011181 potassium carbonates Nutrition 0.000 claims description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 2
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims description 2
- 150000007530 organic bases Chemical class 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 2
- 239000012312 sodium hydride Substances 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims 1
- QNEFNFIKZWUAEQ-UHFFFAOYSA-N carbonic acid;potassium Chemical compound [K].OC(O)=O QNEFNFIKZWUAEQ-UHFFFAOYSA-N 0.000 claims 1
- -1 carboxyl methyl Chemical group 0.000 claims 1
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 18
- 239000002994 raw material Substances 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 7
- 238000009776 industrial production Methods 0.000 abstract description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract description 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000032050 esterification Effects 0.000 abstract 1
- 238000005886 esterification reaction Methods 0.000 abstract 1
- 125000003147 glycosyl group Chemical group 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000011935 selective methylation Methods 0.000 abstract 1
- 244000134552 Plantago ovata Species 0.000 description 28
- 230000015572 biosynthetic process Effects 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 11
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 9
- 238000005160 1H NMR spectroscopy Methods 0.000 description 9
- 229940126214 compound 3 Drugs 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- 238000006257 total synthesis reaction Methods 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 229940125782 compound 2 Drugs 0.000 description 5
- BTQAJGSMXCDDAJ-UHFFFAOYSA-N 2,4,6-trihydroxybenzaldehyde Chemical compound OC1=CC(O)=C(C=O)C(O)=C1 BTQAJGSMXCDDAJ-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- XLEYFDVVXLMULC-UHFFFAOYSA-N 2',4',6'-trihydroxyacetophenone Chemical compound CC(=O)C1=C(O)C=C(O)C=C1O XLEYFDVVXLMULC-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000032612 Glial tumor Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- UWARRXZVZDFPQU-UHFFFAOYSA-N Sorbifolin Natural products C=1C(=O)C=2C(O)=C(O)C(OC)=CC=2OC=1C1=CC=C(O)C=C1 UWARRXZVZDFPQU-UHFFFAOYSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000003262 anti-osteoporosis Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IHFBPDAQLQOCBX-UHFFFAOYSA-N hispidulin Chemical compound C=1C(=O)C2=C(O)C(OC)=C(O)C=C2OC=1C1=CC=C(O)C=C1 IHFBPDAQLQOCBX-UHFFFAOYSA-N 0.000 description 1
- OETSANFHEJPBHW-UHFFFAOYSA-N hispidulin Natural products COc1cc2c(cc1O)oc(cc2=O)-c1ccc(O)cc1 OETSANFHEJPBHW-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/40—Separation, e.g. from natural material; Purification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
Abstract
本发明涉及化学合成领域,涉及一种高车前素新的制备方法,具体涉及利用灯盏花乙素为原料制备合成高车前素的方法。本发明方法以灯盏花乙素为原料,通过羧基酯化、选择性甲基化以及糖基水解三步反应,可以高效地半合成高车前素。本发明的反应步骤少,仅有3步,反应收率高,反应试剂廉价易得,生产成本低;反应条件温和,无苛刻反应条件,易于操作,适宜工业化生产。The invention relates to the field of chemical synthesis, and relates to a new preparation method of psyllium, in particular to a method for preparing synthetic psyllium by using scutellarin as a raw material. The method of the invention uses scutellarin as a raw material, and can efficiently semi-synthesize homophysate through the three-step reaction of carboxyl esterification, selective methylation and glycosyl hydrolysis. The invention has few reaction steps, only 3 steps, high reaction yield, cheap and easily available reaction reagents, low production cost; mild reaction conditions, no harsh reaction conditions, easy operation, and suitability for industrial production.
Description
技术领域technical field
本发明涉及化学合成领域,涉及一种高车前素新的制备方法,具体涉及利用灯盏花乙素为原料制备合成高车前素的方法。The invention relates to the field of chemical synthesis, and relates to a new preparation method of psyllium, in particular to a method for preparing synthetic psyllium by using scutellarin as a raw material.
背景技术Background technique
资料公开了高车前素又名粗毛豚草素(hispidulin)是从新疆雪莲中提取得到的一种黄酮类有效成分。近年来,国内外研究表明高车前素具有抗菌、抗炎、抗氧化、抗血栓、抗癫痫、抗骨质疏松、抗诱变和神经保护等作用,。对人胰腺癌、胃癌、卵巢癌、胶质瘤等细胞株的增殖有明显抑制作用。The data discloses that psyllium, also known as hispidulin, is an active ingredient of flavonoids extracted from Xinjiang snow lotus. In recent years, studies at home and abroad have shown that high psyllium has antibacterial, anti-inflammatory, antioxidant, antithrombotic, antiepileptic, antiosteoporotic, antimutagenic and neuroprotective effects. It has obvious inhibitory effect on the proliferation of human pancreatic cancer, gastric cancer, ovarian cancer, glioma and other cell lines.
研究显示,高车前素具有广泛的生物活性,本领域有关药理学家及药物化学工作者对该化合物均表现出越来越浓厚的兴趣;目前对高车前素的制备合成方法主要包括半合成、全合成以及酶法合成三种。Studies have shown that psyllium has a wide range of biological activities, and pharmacologists and medicinal chemists in the field have shown more and more interest in this compound; the current preparation and synthesis methods of psyllium mainly include semi-synthetic methods. Synthetic, total synthesis and enzymatic synthesis.
关于高车前素的半合成文献报道来自同一课题组:2013--2015年期间研究者在四篇文献中均报道了以灯盏花乙素为起始原料来半合成制备高车前素;其中,以灯盏花乙素为原料分别以7步反应10.7%的总收率(Shen M.Z.et al.Lett.Org.Chem.2013,10,733–737)、7步反应7.1%的总收率(Lin H.et al.Int.J.Mol.Sci.2015,16,7587-7594.)、4步反应6.3%的总收率(Zhang W.et al.Molecules 2015,20,10184-10191.)以及4步反应8.2%的总收率(Zhang W.et al.J.Chem.Res.2015,39,674-676.)完成了高车前素的半合成,但遗憾的是有关报道的半合成制备得到的高车前素核磁波谱数据均与提取分离得到的高车前素以及全合成得到的高车前素的核磁波谱数据有较大差别,证明所述半合成制备得到的高车前素结构存在错误,即:所述研究中以灯盏花乙素为起始原料均未制备得到高车前素。Semi-synthetic literature reports on psyllium are from the same research group: from 2013 to 2015, researchers reported the semi-synthetic preparation of psyllium using scutellarin as the starting material in four literatures; , using scutellarin as raw material, the total yield of 7-step reaction was 10.7% (Shen M.Z. et al. Lett. Org. Chem. 2013, 10, 733-737), and the total yield of 7-step reaction was 7.1% (Lin H .et al.Int.J.Mol.Sci.2015, 16, 7587-7594.), 6.3% overall yield in 4-step reaction (Zhang W. et al. Molecules 2015, 20, 10184-10191.) and 4 The total yield of 8.2% in the first step reaction (Zhang W. et al. J. Chem. Res. 2015, 39, 674-676.) completed the semi-synthesis of homophysate, but unfortunately, the reported semi-synthetic preparation was obtained The NMR spectral data of psyllium are quite different from those of psyllium obtained by extraction and separation and the NMR data of psyllium obtained by total synthesis, which proves that the structure of psyllium prepared by the semi-synthesis is wrong. That is: in the study, scutellarin was not prepared with scutellarin as the starting material.
关于高车前素的全合成方法有如下文献报道:2004年Kavvadias及其合作者以2,4,6-三羟基苯乙酮为起始原料经9步反应以1.1%的总收率完成高车前素的化学全合成;(Kavvadias D.et al.Br.J.Pharmacol.2004,142,811–820.)2015年Chao等以2,4,6-三羟基苯甲醛为起始原料经11步反应完成高车前素的化学全合成,但总收率仅有1.6%;(ChaoS.W.et al.J.Nat.Prod.2015,78,1969-1976.)为提高反应收率以制备得到足够的量来满足生物活性研究的需要,随后Chen等对合成路线进行了优化改进,同样以2,4,6-三羟基苯甲醛为起始原料,最终经8步反应以26.9%的总收率完成对该化合物的全合成,(ChenL.C.et al.Molecules2017,22,1897-1910.),上述三种全合成制得的高车前素的核磁波谱数据均与原始文献中提取分离得到的高车前素的核磁波谱数据一致。The total synthesis method of high psyllium is reported in the following literature: in 2004, Kavvadias and his collaborators used 2,4,6-trihydroxyacetophenone as the starting material to complete the high-grade phytoplankton with a total yield of 1.1% through 9 steps of reaction. Total chemical synthesis of psyllium; (Kavvadias D. et al. Br. J. Pharmacol. 2004, 142, 811–820.) In 2015, Chao et al. took 2,4,6-trihydroxybenzaldehyde as the starting material through 11 steps The reaction completes the chemical total synthesis of high phytoplankton, but the total yield is only 1.6%; (ChaoS.W.et al.J.Nat.Prod.2015,78,1969-1976.) In order to improve the reaction yield to prepare A sufficient amount was obtained to meet the needs of biological activity research, and then Chen et al. optimized and improved the synthetic route, also using 2,4,6-trihydroxybenzaldehyde as the starting material, and finally obtained 26.9% of the total through 8-step reaction. The total synthesis of the compound was completed in yield, (ChenL.C.et al.Molecules2017,22,1897-1910.), the nuclear magnetic spectrum data of the above three kinds of total synthesis of psyllium were extracted from the original literature The NMR data of the isolated psyllium were consistent.
山东大学药学院报道了高车前素的酶法合成:使用地钱黄酮6-O-甲基转移酶可以高效的对野黄芩素的6-为酚羟基选择性甲基化制备得到高车前素(Zhang Y.Y.et al.FEBSLetters,2016,590,2619-2628),利用酶促合成制备得到的高车前素的核磁波谱数据与原始文献中提取分离得到的高车前素的核磁波谱数据一致,但实践显示,上述制备方法中所使用的地钱黄酮6-O-甲基转移酶利用基因重组的方式获得,存在周期较长、酶的纯化量较小、不适宜大规模工业化等缺陷。The enzymatic synthesis of psyllium is reported by the School of Pharmacy of Shandong University: the 6-O-methyltransferase of dichnium can efficiently selectively methylate the 6-phenolic hydroxyl group of scutellarin to obtain psyllium (Zhang Y.Y. et al. FEBSLetters, 2016, 590, 2619-2628), the NMR data of psyllium obtained by enzymatic synthesis are consistent with the NMR data of psyllium extracted and isolated from the original literature , but practice shows that the 6-O-methyltransferase used in the above preparation method is obtained by gene recombination, which has the defects of long cycle, small purification amount of enzyme, and unsuitable for large-scale industrialization.
基于现有技术的现状,本申请的发明人拟提供一种高车前素新的制备方法。Based on the current state of the prior art, the inventors of the present application intend to provide a new preparation method of phytoplankton.
发明内容SUMMARY OF THE INVENTION
本发明的目的是为了解决现有技术的不足,提供一种高车前素新的制备方法,具体涉及利用灯盏花乙素为原料制备合成高车前素的方法。The purpose of the present invention is to solve the deficiencies of the prior art, and provide a new preparation method of psyllium, in particular to a method for preparing synthetic psyllium by using scutellarin as a raw material.
本发明以灯盏花乙素为起始原料半合成制备高车前素,合成步骤短,成本低,收率高,产品纯度高,适于工业化生产。The invention takes scutellarin as a starting material for semi-synthetic preparation of high psyllium, has short synthesis steps, low cost, high yield and high product purity, and is suitable for industrial production.
为了实现上述目的,本发明采用如下技术方案:In order to achieve the above object, the present invention adopts the following technical solutions:
本发明的制备方法为,按如下反应式:Preparation method of the present invention is, according to following reaction formula:
本发明提供的一种高车前素的合成方法,具体包含以下步骤:A kind of synthetic method of phytoplankton provided by the invention specifically comprises the following steps:
a:以灯盏花乙素为起始原料,在酸性催化剂条件下将羧基甲酯化,得到灯盏花乙素甲酯(化合物2);A: take scutellarin as starting material, under acidic catalyst conditions, carboxyl is methylated to obtain scutellarin methyl ester (compound 2);
b:将上述生成的灯盏花乙素甲酯(化合物2)在缚酸剂存在下与碘甲烷发生亲核取代反应,生成6-OMe灯盏花乙素甲酯(化合物3);b: scutellarin methyl ester (compound 2) generated above is nucleophilic substitution reaction with methyl iodide in the presence of acid binding agent to generate 6-OMe scutellarin methyl ester (compound 3);
c:将上述生成的化合物3在酸性催化剂作用下发生糖苷键水解反应,得到目标化合物4。c: subjecting the above-generated compound 3 to a hydrolysis reaction of the glycosidic bond under the action of an acidic catalyst to obtain the target compound 4.
上述反应a步骤采用的反应溶剂为甲醇。The reaction solvent adopted in the above-mentioned reaction a step is methanol.
上述反应a步骤采用的酸性催化剂为氯化亚砜、高氯酸、浓硫酸、浓硝酸、三氟乙酸、浓盐酸中的一种或它们的混合物,优选氯化亚砜或浓硫酸。The acid catalyst adopted in the above-mentioned reaction a step is one of thionyl chloride, perchloric acid, concentrated sulfuric acid, concentrated nitric acid, trifluoroacetic acid, concentrated hydrochloric acid or a mixture thereof, preferably thionyl chloride or concentrated sulfuric acid.
上述反应a步骤中灯盏花乙素在甲醇溶液中的浓度优选10~100mg mL-1,进一步优选20~30mg mL-1。The concentration of scutellarin in the methanol solution in the step a of the above reaction is preferably 10-100 mg mL -1 , more preferably 20-30 mg mL -1 .
上述反应b步骤采用的缚酸剂为无机碱如:碳酸钾、碳酸铯、碳酸钠、氢化钠、碳酸氢钾、碳酸氢钠中的一种或它们的混合物;有机碱如:N,N-二异丙基乙胺、三乙胺、乙二胺、DBU中的一种或它们的混合物,优选无机碱碳酸钾。The acid binding agent that above-mentioned reaction b step adopts is inorganic base such as: a kind of or their mixture in potassium carbonate, cesium carbonate, sodium carbonate, sodium hydride, potassium bicarbonate, sodium bicarbonate; Organic base such as: N,N- One of diisopropylethylamine, triethylamine, ethylenediamine, DBU or their mixture, preferably inorganic alkali potassium carbonate.
上述反应b步骤采用的有机溶剂为N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、丙酮、乙腈、四氢呋喃、氯仿、乙酸乙酯中的一种或它们的混合物,优选N,N-二甲基甲酰胺或N,N-二甲基乙酰胺。The organic solvent that the above-mentioned reaction b step adopts is a kind of or their mixture in N,N-dimethylformamide, N,N-dimethylacetamide, acetone, acetonitrile, tetrahydrofuran, chloroform, ethyl acetate, preferably N,N-dimethylformamide or N,N-dimethylacetamide.
上述反应b步骤中灯盏花花乙素甲酯与碘甲烷的摩尔比优选1:1~1:2,进一步优选1:1.2。In the above-mentioned reaction b step, the molar ratio of scutellarin methyl ester and methyl iodide is preferably 1:1 to 1:2, more preferably 1:1.2.
上述反应c步骤采用的酸性催化剂为浓硫酸、浓盐酸、浓硝酸、三氟乙酸中的一种或它们的混合物,优选浓硫酸。The acid catalyst adopted in the above-mentioned reaction c step is one of concentrated sulfuric acid, concentrated hydrochloric acid, concentrated nitric acid, and trifluoroacetic acid or a mixture thereof, preferably concentrated sulfuric acid.
上述反应c步骤采用的反应溶剂为乙醇、甲醇、异丙醇、乙腈、水中的一种或它们的混合物,优选90%乙醇。The reaction solvent used in the above-mentioned reaction c step is one of ethanol, methanol, isopropanol, acetonitrile, water or a mixture thereof, preferably 90% ethanol.
上述反应c步骤反应温度优选60~150℃,进一步优选100~120℃。The reaction temperature in the step c of the above reaction is preferably 60 to 150°C, more preferably 100 to 120°C.
本发明制得的高车前素的核磁波谱数据与原始文献中提取分离得到的高车前素的核磁波谱数据一致。The nuclear magnetic spectrum data of psyllium obtained by the present invention is consistent with the nuclear magnetic spectrum data of psyllium extracted and separated from the original document.
本发明与现有技术相比具有以下优点:Compared with the prior art, the present invention has the following advantages:
反应步骤少,仅有3步,为目前为止制备高车前素的最短合成路线;反应收率高,反应收率明显高于现有文献报道;反应试剂廉价易得,生产成本低;反应条件温和,无苛刻反应条件,适宜工业化生产。There are few reaction steps, only 3 steps, which is the shortest synthetic route for preparing high psyllium so far; the reaction yield is high, and the reaction yield is obviously higher than that reported in the existing literature; the reaction reagents are cheap and easy to obtain, and the production cost is low; the reaction conditions Mild, no harsh reaction conditions, suitable for industrial production.
根据下述实施例,可以更好地理解本发明。然而,本领域的技术人员容易理解,所述实施例所描述的具体物料配比、工艺条件及其结果仅用于说明本发明,而不应当也不会限制本发明。The present invention can be better understood from the following examples. However, those skilled in the art can easily understand that the specific material ratios, process conditions and results described in the examples are only used to illustrate the present invention, and should not and will not limit the present invention.
具体实施方式Detailed ways
实施例1:合成灯盏花乙素甲酯2Embodiment 1: Synthesis of scutellarin methyl ester 2
500mL圆底烧瓶中加入200mL无水甲醇,冰浴下缓慢滴加SOCl2(7.25mL,100mmol),滴加完毕撤去冰浴,室温继续搅拌1h。然后加入灯盏花乙素1(4.62g,10mmol),室温搅拌9h后,TLC(V乙酸乙酯:V异丙醇:V水=4:2:1)反应完全;直接过滤得灯盏花乙素甲酯2(4.67g,98%);1H-NMR(400MHz,DMSO-d6)δ12.85(s,1H,5-OH),10.39(s,1H,4’-OH),7.93(d,J=9.0Hz,2H,H-2’,H-6’),7.00(s,1H,H-8),6.94(d,J=9.0Hz,2H,H-3’,H-5’),6.81(s,1H,H-3),5.28(d,J=7.0Hz,1H,H-1”),4.20(d,J=6.0Hz,1H,H-2”),3.70-3.90(3H,m,other sugarprotons),3.68(3H,s,-OCH3);13C-NMR(125MHz,DMSO-d6):δ182.8,169.7,164.5,161.6,151.3,149.4,147.3,130.8,128.9,121.7,116.4,106.3,102.9,100.2,93.9,75.7,75.4,73.1,71.8,52.4(-OCH3)。Add 200 mL of anhydrous methanol to a 500 mL round-bottomed flask, slowly add SOCl 2 (7.25 mL, 100 mmol) dropwise under an ice bath, remove the ice bath after the dropwise addition, and continue stirring at room temperature for 1 h. Then add scutellarin 1 (4.62g, 10mmol), after stirring at room temperature for 9h, TLC (V ethyl acetate :V isopropanol :V water =4:2:1) reaction is complete; direct filtration to obtain scutellarin Methyl ester 2 (4.67 g, 98%); 1 H-NMR (400 MHz, DMSO-d 6 ) δ 12.85 (s, 1H, 5-OH), 10.39 (s, 1H, 4'-OH), 7.93 ( d,J=9.0Hz,2H,H-2',H-6'),7.00(s,1H,H-8),6.94(d,J=9.0Hz,2H,H-3',H-5 '), 6.81(s, 1H, H-3), 5.28(d, J=7.0Hz, 1H, H-1"), 4.20(d, J=6.0Hz, 1H, H-2"), 3.70- 3.90(3H,m,other sugarprotons), 3.68(3H,s,-OCH3); 13 C-NMR (125MHz, DMSO-d 6 ): δ182.8, 169.7, 164.5, 161.6, 151.3, 149.4, 147.3, 130.8, 128.9 , 121.7, 116.4, 106.3, 102.9, 100.2, 93.9, 75.7, 75.4, 73.1, 71.8, 52.4 (-OCH 3 ).
实施例2:合成灯盏花乙素甲酯2Embodiment 2: Synthesis of scutellarin methyl ester 2
500mL圆底烧瓶中将灯盏花乙素1(4.62g,10mmol)悬浮于300mL无水甲醇,室温下缓慢滴加浓硫酸(0.03mL),滴加完毕,加热回流3h后,TLC(V乙酸乙酯:V异丙醇:V水=4:2:1)反应完全。自然冷却至室温后减压浓缩得灯盏花乙素甲酯2(4.72g,98%)。1H-NMR(400MHz,DMSO-d6)δ12.85(s,1H,5-OH),10.39(s,1H,4’-OH),7.93(d,J=9.0Hz,2H,H-2’,H-6’),7.00(s,1H,H-8),6.94(d,J=9.0Hz,2H,H-3’,H-5’),6.81(s,1H,H-3),5.28(d,J=7.0Hz,1H,H-1”),4.20(d,J=6.0Hz,1H,H-2”),3.70-3.90(3H,m,other sugar protons),3.68(3H,s,-OCH3);13C-NMR(125MHz,DMSO-d6):δ182.8,169.7,164.5,161.6,151.3,149.4,147.3,130.8,128.9,121.7,116.4,106.3,102.9,100.2,93.9,75.7,75.4,73.1,71.8,52.4(-OCH3)。In a 500 mL round-bottomed flask, scutellarin 1 (4.62 g, 10 mmol) was suspended in 300 mL of anhydrous methanol, and concentrated sulfuric acid (0.03 mL) was slowly added dropwise at room temperature. Ester :V isopropanol :V water =4:2:1) The reaction is complete. Naturally cooled to room temperature and concentrated under reduced pressure to obtain scutellarin methyl ester 2 (4.72 g, 98%). 1 H-NMR (400MHz, DMSO-d 6 )δ12.85(s,1H,5-OH),10.39(s,1H,4'-OH),7.93(d,J=9.0Hz,2H,H- 2',H-6'),7.00(s,1H,H-8),6.94(d,J=9.0Hz,2H,H-3',H-5'),6.81(s,1H,H- 3), 5.28(d, J=7.0Hz, 1H, H-1”), 4.20(d, J=6.0Hz, 1H, H-2”), 3.70-3.90(3H, m, other sugar protons), 3.68 (3H, s, -OCH3); 13 C-NMR (125MHz, DMSO-d 6 ): δ182.8, 169.7, 164.5, 161.6, 151.3, 149.4, 147.3, 130.8, 128.9, 121.7, 116.4, 106.3, 102.9, 100.2 , 93.9, 75.7, 75.4, 73.1, 71.8, 52.4 (-OCH 3 ).
实施例3:合成灯盏花乙素甲酯2Embodiment 3: Synthesis of scutellarin methyl ester 2
500mL圆底烧瓶中将灯盏花乙素1(4.62g,10mmol)悬浮于200mL无水甲醇,室温下缓慢滴加70%高氯酸(0.03mL)。滴加完毕,加热回流3h后,TLC(V乙酸乙酯:V异丙醇:V水=4:2:1)反应完全,自然冷却至室温后减压浓缩得灯盏花乙素甲酯2(4.72g,98%)。1H-NMR(400MHz,DMSO-d6)δ12.85(s,1H,5-OH),10.39(s,1H,4’-OH),7.93(d,J=9.0Hz,2H,H-2’,H-6’),7.00(s,1H,H-8),6.94(d,J=9.0Hz,2H,H-3’,H-5’),6.81(s,1H,H-3),5.28(d,J=7.0Hz,1H,H-1”),4.20(d,J=6.0Hz,1H,H-2”),3.70-3.90(3H,m,other sugar protons),3.68(3H,s,-OCH3);13C-NMR(125MHz,DMSO-d6):δ182.8,169.7,164.5,161.6,151.3,149.4,147.3,130.8,128.9,121.7,116.4,106.3,102.9,100.2,93.9,75.7,75.4,73.1,71.8,52.4(-OCH3)。In a 500 mL round-bottomed flask, scutellarin 1 (4.62 g, 10 mmol) was suspended in 200 mL of anhydrous methanol, and 70% perchloric acid (0.03 mL) was slowly added dropwise at room temperature. The dropwise addition was completed, and after heating to reflux for 3h, TLC (V ethyl acetate :V isopropanol :V water =4:2:1) reacted completely, naturally cooled to room temperature and then concentrated under reduced pressure to obtain scutellarin methyl ester 2( 4.72g, 98%). 1 H-NMR (400MHz, DMSO-d 6 )δ12.85(s,1H,5-OH),10.39(s,1H,4'-OH),7.93(d,J=9.0Hz,2H,H- 2',H-6'),7.00(s,1H,H-8),6.94(d,J=9.0Hz,2H,H-3',H-5'),6.81(s,1H,H- 3), 5.28(d, J=7.0Hz, 1H, H-1”), 4.20(d, J=6.0Hz, 1H, H-2”), 3.70-3.90(3H, m, other sugar protons), 3.68 (3H, s, -OCH3); 13 C-NMR (125MHz, DMSO-d 6 ): δ182.8, 169.7, 164.5, 161.6, 151.3, 149.4, 147.3, 130.8, 128.9, 121.7, 116.4, 106.3, 102.9, 100.2 , 93.9, 75.7, 75.4, 73.1, 71.8, 52.4 (-OCH 3 ).
实施例4:合成6-OMe灯盏花乙素甲酯3Example 4: Synthesis of 6-OMe scutellarin methyl ester 3
250mL圆底烧瓶中将化合物2(3.81g,8.0mmol)溶于50mLN,N-二甲基甲酰胺中,室温搅拌下加入无水K2CO3(1.66g,12.0mmol),氮气保护下滴加MeI(0.60mL,9.6mmol),40℃下搅拌过夜后,TLC(V二氯甲烷:V甲醇=20:1)原料消失,将反应体系倒入50mL冰水中,乙酸乙酯(25mL×3)萃取,饱和食盐水洗,无水硫酸钠干燥,浓缩,柱层析得化合物3(1.53g,39%);1H-NMR(400MHz,DMSO-d6)δ12.98(s,1H,5-OH),10.42(s,1H,4’-OH),7.95(d,J=7.8Hz,2H,H-2’,H-6’),7.07(s,1H,H-8),6.95(d,J=8.1Hz,2H,H-3’,H-5’),6.86(s,1H,H-3),5.62(d,J=3.9Hz,1H),5.52(d,J=5.3Hz,1H,H-1”),5.36(d,J=4.9Hz,2H),4.20(d,J=9.1Hz,1H),3.76(s,3H,-OCH3),3.66(s,3H,-OCH3);13C-NMR(125MHz,DMSO-d6):δ182.33,169.22,164.38,161.38,155.94,152.68,152.13,132.53,128.59,121.11,116.02,105.92,102.77,99.39,93.91,75.67,75.30,72.81,71.34,60.33,52.03。In a 250mL round-bottomed flask, compound 2 (3.81g, 8.0mmol) was dissolved in 50mL of N,N-dimethylformamide, and anhydrous K 2 CO 3 (1.66g, 12.0 mmol) was added under stirring at room temperature, and dropped under nitrogen protection. MeI (0.60 mL, 9.6 mmol) was added, and after stirring at 40°C overnight, TLC (V dichloromethane :V methanol =20:1) raw materials disappeared, the reaction system was poured into 50 mL of ice water, ethyl acetate (25 mL×3 ) extraction, washed with saturated brine, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain compound 3 (1.53g, 39%); 1 H-NMR (400MHz, DMSO-d 6 )δ12.98(s, 1H, 5 -OH), 10.42(s, 1H, 4'-OH), 7.95(d, J=7.8Hz, 2H, H-2', H-6'), 7.07(s, 1H, H-8), 6.95 (d,J=8.1Hz,2H,H-3',H-5'),6.86(s,1H,H-3),5.62(d,J=3.9Hz,1H),5.52(d,J= 5.3Hz,1H,H-1”),5.36(d,J=4.9Hz,2H),4.20(d,J=9.1Hz,1H),3.76(s,3H,-OCH3),3.66(s,3H ,-OCH3); 13 C-NMR (125MHz, DMSO-d 6 ): δ182.33, 169.22, 164.38, 161.38, 155.94, 152.68, 152.13, 132.53, 128.59, 121.11, 116.02, 105.92, 102.77, 5, 9.39 75.30, 72.81, 71.34, 60.33, 52.03.
实施例5:合成6-OMe灯盏花乙素甲酯3Example 5: Synthesis of 6-OMe scutellarin methyl ester 3
250mL圆底烧瓶中将化合物2(3.81g,8.0mmol)溶于50mLN,N-二甲基乙酰胺中,室温搅拌下加入无水K2CO3(1.66g,12.0mmol),氮气保护下滴加MeI(0.75mL,12.0mmol),40℃下搅拌过夜后,TLC(V二氯甲烷:V甲醇=20:1)原料消失,将反应体系倒入50mL冰水中,乙酸乙酯(25mL×3)萃取,饱和食盐水洗,无水硫酸钠干燥,浓缩,柱层析得化合物3(1.26g,32%);1H-NMR(400MHz,DMSO-d6)δ12.98(s,1H,5-OH),10.42(s,1H,4’-OH),7.95(d,J=7.8Hz,2H,H-2’,H-6’),7.07(s,1H,H-8),6.95(d,J=8.1Hz,2H,H-3’,H-5’),6.86(s,1H,H-3),5.62(d,J=3.9Hz,1H),5.52(d,J=5.3Hz,1H,H-1”),5.36(d,J=4.9Hz,2H),4.20(d,J=9.1Hz,1H),3.76(s,3H,-OCH3),3.66(s,3H,-OCH3);13C-NMR(125MHz,DMSO-d6):δ182.33,169.22,164.38,161.38,155.94,152.68,152.13,132.53,128.59,121.11,116.02,105.92,102.77,99.39,93.91,75.67,75.30,72.81,71.34,60.33,52.03。Compound 2 (3.81 g, 8.0 mmol) was dissolved in 50 mL of N,N-dimethylacetamide in a 250 mL round-bottomed flask, and anhydrous K 2 CO 3 (1.66 g, 12.0 mmol) was added under stirring at room temperature, and dropped under nitrogen protection. MeI (0.75 mL, 12.0 mmol) was added, and after stirring overnight at 40°C, TLC (V dichloromethane :V methanol = 20:1) raw materials disappeared, the reaction system was poured into 50 mL of ice water, ethyl acetate (25 mL × 3 ) extraction, washed with saturated brine, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain compound 3 (1.26g, 32%); 1 H-NMR (400MHz, DMSO-d 6 )δ12.98(s, 1H, 5 -OH), 10.42(s, 1H, 4'-OH), 7.95(d, J=7.8Hz, 2H, H-2', H-6'), 7.07(s, 1H, H-8), 6.95 (d,J=8.1Hz,2H,H-3',H-5'),6.86(s,1H,H-3),5.62(d,J=3.9Hz,1H),5.52(d,J= 5.3Hz, 1H, H-1”), 5.36(d, J=4.9Hz, 2H), 4.20(d, J=9.1Hz, 1H), 3.76(s, 3H, -OCH3), 3.66(s, 3H ,-OCH3); 13 C-NMR (125MHz, DMSO-d 6 ): δ182.33, 169.22, 164.38, 161.38, 155.94, 152.68, 152.13, 132.53, 128.59, 121.11, 116.02, 105.92, 102.77, 5, 9.39 75.30, 72.81, 71.34, 60.33, 52.03.
实施例6:合成6-OMe灯盏花乙素甲酯3Example 6: Synthesis of 6-OMe scutellarin methyl ester 3
250mL圆底烧瓶中将化合物2(3.81g,8.0mmol)溶于50mLN,N-二甲基甲酰胺中,室温搅拌下加入无水DIPEA(1.98mL,12.0mmol),氮气保护下滴加MeI(0.60mL,9.6mmol),40℃下搅拌过夜后,TLC(V二氯甲烷:V甲醇=20:1)原料消失,将反应体系倒入50mL冰水中,乙酸乙酯(25mL×3)萃取,饱和食盐水洗,无水硫酸钠干燥,浓缩,柱层析得化合物3(1.14g,29%);1H-NMR(400MHz,DMSO-d6)δ12.98(s,1H,5-OH),10.42(s,1H,4’-OH),7.95(d,J=7.8Hz,2H,H-2’,H-6’),7.07(s,1H,H-8),6.95(d,J=8.1Hz,2H,H-3’,H-5’),6.86(s,1H,H-3),5.62(d,J=3.9Hz,1H),5.52(d,J=5.3Hz,1H,H-1”),5.36(d,J=4.9Hz,2H),4.20(d,J=9.1Hz,1H),3.76(s,3H,-OCH3),3.66(s,3H,-OCH3);13C-NMR(125MHz,DMSO-d6):δ182.33,169.22,164.38,161.38,155.94,152.68,152.13,132.53,128.59,121.11,116.02,105.92,102.77,99.39,93.91,75.67,75.30,72.81,71.34,60.33,52.03。Compound 2 (3.81 g, 8.0 mmol) was dissolved in 50 mL of N,N-dimethylformamide in a 250 mL round-bottomed flask, anhydrous DIPEA (1.98 mL, 12.0 mmol) was added under stirring at room temperature, and MeI ( 0.60mL, 9.6mmol), after stirring overnight at 40°C, TLC (V dichloromethane :V methanol =20:1) raw materials disappeared, the reaction system was poured into 50mL ice water, extracted with ethyl acetate (25mL×3), Washed with saturated brine, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain compound 3 (1.14 g, 29%); 1 H-NMR (400 MHz, DMSO-d 6 )δ12.98 (s, 1H, 5-OH) ,10.42(s,1H,4'-OH),7.95(d,J=7.8Hz,2H,H-2',H-6'),7.07(s,1H,H-8),6.95(d, J=8.1Hz, 2H, H-3', H-5'), 6.86(s, 1H, H-3), 5.62(d, J=3.9Hz, 1H), 5.52(d, J=5.3Hz, 1H,H-1”), 5.36(d,J=4.9Hz,2H), 4.20(d,J=9.1Hz,1H), 3.76(s,3H,-OCH3), 3.66(s,3H,-OCH3 ); 13 C-NMR (125MHz, DMSO-d 6 ): δ182.33, 169.22, 164.38, 161.38, 155.94, 152.68, 152.13, 132.53, 128.59, 121.11, 116.02, 105.92, 102.77, 97.3, 9, 9,30,9 , 71.34, 60.33, 52.03.
实施例7:合成高车前素4Example 7: Synthesis of Holocene 4
250mL圆底烧瓶中将化合物3(4.19g,8.55mmol)悬浮于135mL乙醇与18.8mL水的混合溶剂,室温搅拌下滴加浓硫酸18.8mL,滴加完毕100℃回流过夜,TLC(V二氯甲烷:V甲醇=20:1)原料消失。自然冷却至室温,水洗,乙酸乙酯(100mL×3)萃取,饱和食盐水洗,无水硫酸钠干燥,浓缩,柱层析得高车前素(2.33g,91%);1H-NMR(400MHz,DMSO-d6)δ13.05(s,1H),10.72(s,1H),10.37(s,1H),7.92(d,J=8.5Hz,2H),6.92(d,J=8.5Hz,2H),6.77(s,1H),6.59(s,1H),3.74(s,3H);13C-NMR(125MHz,DMSO-d6):δ182.18,163.86,161.20,157.28,152.81,152.43,131.38,128.51,121.25,116.00,104.12,102.41,94.28,60.00。Compound 3 (4.19 g , 8.55 mmol) was suspended in a mixed solvent of 135 mL of ethanol and 18.8 mL of water in a 250 mL round-bottomed flask, and 18.8 mL of concentrated sulfuric acid was added dropwise with stirring at room temperature. Methane :V methanol =20:1) The raw material disappeared. Naturally cooled to room temperature, washed with water, extracted with ethyl acetate (100 mL×3), washed with saturated brine, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain psyllium (2.33 g, 91%); 1 H-NMR ( 400MHz, DMSO-d 6 )δ13.05(s, 1H), 10.72(s, 1H), 10.37(s, 1H), 7.92(d, J=8.5Hz, 2H), 6.92(d, J=8.5Hz) , 2H), 6.77(s, 1H), 6.59(s, 1H), 3.74(s, 3H); 13 C-NMR (125MHz, DMSO-d 6 ): δ182.18, 163.86, 161.20, 157.28, 152.81, 152.43, 131.38, 128.51, 121.25, 116.00, 104.12, 102.41, 94.28, 60.00.
实施例8:合成高车前素4Example 8: Synthesis of Holocene 4
250mL圆底烧瓶中将化合物3(4.19g,8.55mmol)悬浮于135mL异丙醇与18.8mL水的混合溶剂,室温搅拌下滴加浓硫酸18.8mL,滴加完毕120℃回流过夜,TLC(V二氯甲烷:V甲醇=20:1)原料消失,自然冷却至室温,水洗,乙酸乙酯(100mL×3)萃取,饱和食盐水洗,无水硫酸钠干燥,浓缩,柱层析得高车前素(2.30g,90%);1H-NMR(400MHz,DMSO-d6)δ13.05(s,1H),10.72(s,1H),10.37(s,1H),7.92(d,J=8.5Hz,2H),6.92(d,J=8.5Hz,2H),6.77(s,1H),6.59(s,1H),3.74(s,3H);13C-NMR(125MHz,DMSO-d6):δ182.18,163.86,161.20,157.28,152.81,152.43,131.38,128.51,121.25,116.00,104.12,102.41,94.28,60.00。In a 250mL round-bottomed flask, compound 3 (4.19g, 8.55mmol) was suspended in a mixed solvent of 135mL isopropanol and 18.8mL water, and 18.8mL of concentrated sulfuric acid was added dropwise with stirring at room temperature. Dichloromethane :V methanol =20:1) the raw materials disappeared, naturally cooled to room temperature, washed with water, extracted with ethyl acetate (100 mL×3), washed with saturated brine, dried over anhydrous sodium sulfate, concentrated, and obtained by column chromatography element (2.30g, 90%); 1 H-NMR (400MHz, DMSO-d 6 )δ13.05(s, 1H), 10.72(s, 1H), 10.37(s, 1H), 7.92(d, J= 8.5Hz, 2H), 6.92(d, J=8.5Hz, 2H), 6.77(s, 1H), 6.59(s, 1H), 3.74(s, 3H); 13 C-NMR (125MHz, DMSO-d 6 ): δ182.18, 163.86, 161.20, 157.28, 152.81, 152.43, 131.38, 128.51, 121.25, 116.00, 104.12, 102.41, 94.28, 60.00.
实施例9:合成高车前素4Example 9: Synthesis of Holocene 4
250mL圆底烧瓶中将化合物3(4.19g,8.55mmol)悬浮于135mL乙醇与18.8mL水的混合溶剂,室温搅拌下滴加浓盐酸18.8mL,滴加完毕100℃回流过夜,TLC(V二氯甲烷:V甲醇=20:1)原料消失,自然冷却至室温,水洗,乙酸乙酯(100mL×3)萃取,饱和食盐水洗,无水硫酸钠干燥,浓缩,柱层析得高车前素(1.82g,71%);1H-NMR(400MHz,DMSO-d6)δ13.05(s,1H),10.72(s,1H),10.37(s,1H),7.92(d,J=8.5Hz,2H),6.92(d,J=8.5Hz,2H),6.77(s,1H),6.59(s,1H),3.74(s,3H);13C-NMR(125MHz,DMSO-d6):δ182.18,163.86,161.20,157.28,152.81,152.43,131.38,128.51,121.25,116.00,104.12,102.41,94.28,60.00。Compound 3 (4.19g, 8.55mmol) was suspended in a mixed solvent of 135mL ethanol and 18.8mL water in a 250mL round-bottomed flask, 18.8mL of concentrated hydrochloric acid was added dropwise with stirring at room temperature, and the addition was completed at 100 ° C and refluxed overnight, TLC (V dichloride ) Methane :V methanol =20:1) the raw material disappeared, naturally cooled to room temperature, washed with water, extracted with ethyl acetate (100 mL×3), washed with saturated brine, dried over anhydrous sodium sulfate, concentrated, and column chromatography to obtain psyllium ( 1.82g, 71%); 1 H-NMR (400MHz, DMSO-d 6 ) δ 13.05(s, 1H), 10.72(s, 1H), 10.37(s, 1H), 7.92(d, J=8.5Hz , 2H), 6.92(d, J=8.5Hz, 2H), 6.77(s, 1H), 6.59(s, 1H), 3.74(s, 3H); 13 C-NMR (125MHz, DMSO-d 6 ): δ182.18, 163.86, 161.20, 157.28, 152.81, 152.43, 131.38, 128.51, 121.25, 116.00, 104.12, 102.41, 94.28, 60.00.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910083880.6A CN111484471A (en) | 2019-01-29 | 2019-01-29 | A kind of preparation method of high psyllium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910083880.6A CN111484471A (en) | 2019-01-29 | 2019-01-29 | A kind of preparation method of high psyllium |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111484471A true CN111484471A (en) | 2020-08-04 |
Family
ID=71791393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910083880.6A Pending CN111484471A (en) | 2019-01-29 | 2019-01-29 | A kind of preparation method of high psyllium |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111484471A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104311518A (en) * | 2014-11-18 | 2015-01-28 | 南京中医药大学 | Preparation method for 6-methoxyscutellarin |
-
2019
- 2019-01-29 CN CN201910083880.6A patent/CN111484471A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104311518A (en) * | 2014-11-18 | 2015-01-28 | 南京中医药大学 | Preparation method for 6-methoxyscutellarin |
Non-Patent Citations (1)
Title |
---|
颜世强 等: "灯盏花乙素半合成柳穿鱼叶苷研究", 《有机化学》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101657462B (en) | The preparation method and intermediates of capecitabine | |
AU621615B2 (en) | Process for the preparation of dideoxycytidine | |
CN101941999B (en) | Method for preparing scutellarin | |
CN102617678A (en) | Method for preparing gemcitabine hydrochloride | |
Riley et al. | A concise synthesis of neo-inositol | |
US20080167463A1 (en) | Process for Preparation of Gemcitabine Hydrochloride | |
CN104370932A (en) | Process for producing pyripyropene derivative | |
CN106068271A (en) | 2` replaces 2,2` anhydro uridine or 2` replaces 2,2` dehydration cytidine compounds and its production and use | |
WO2013155849A1 (en) | Method for preparing 5,6,4'-trihydroxyflavone-7-0-d-glucuronic acid | |
CN105348341B (en) | A kind of method for preparing rope Citropten | |
CN102336798A (en) | Synthetic method of ginsenoside Rh3 | |
CN111484471A (en) | A kind of preparation method of high psyllium | |
CN101250176A (en) | A kind of flavonol sulfonate derivative and its synthesis method | |
CN104311518B (en) | A kind of preparation method of 6-methyl scutellarin aglycone | |
WO2013123896A1 (en) | Method for preparing 3-o-benzyl-1,2-o-isopropylidene-α-l-furan idose | |
CN100422168C (en) | Hesperetin derivatives and preparation method thereof | |
CN103130855A (en) | Preparation method of decitabine | |
Lu et al. | 2, 4, 5-Trideoxyhexopyranosides Derivatives of 4’-Demethylepipodophyllotoxin: De novo Synthesis and Anticancer Activity | |
CN103374049B (en) | One prepares 5,6, the method for 4 '-trihydroxyflavone-7-0-D-glucuronic acid | |
CN112661802B (en) | Synthetic method of 3' -methoxyguanosine | |
CN111484538B (en) | A kind of preparation method of homopsyllogenin | |
CN101712705B (en) | A class of flavonoid compound intermediates and their preparation methods and applications | |
CN107216361A (en) | The preparation method of rope Citropten | |
CN110143927B (en) | Benzimidazole chalcone derivative and preparation method and application thereof | |
CN107216360B (en) | A method of preparing rope Citropten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200804 |